DKSH Holding AG

DKSH

CH0126673539

Business Support Services

Market Closed - Swiss Exchange Other stock markets 11:31:30 2024-04-26 am EDT			5-day change	1st Jan Change
59.6 ^CHF	-0.17%		-1.49%	+2.05%

Apr. 08	DKSH to Buy Malaysian Provider of Ingredients, Services Elite Organic	MT
Apr. 08	DKSH's Performance Materials Business Unit to Purchase Elite Organic	MT

DKSH Holding AG agreed to acquire Bio-Strategy New Zealand and Bio-Strategy Australia.

November 01, 2023

DKSH Holding AG (SWX:DKSH) signed an agreement to acquire Bio-Strategy New Zealand and Bio-Strategy Australia on November 2, 2023. The transaction is expected during the fourth quarter of 2023 and is subject to certain conditions.

Latest news about DKSH Holding AG

DKSH to Buy Malaysian Provider of Ingredients, Services Elite Organic	Apr. 08	MT
DKSH's Performance Materials Business Unit to Purchase Elite Organic	Apr. 08	MT
DKSH : EPS cut (2023: -5.1%, 2024: +0.9%)	Feb. 19
DKSH Holding AG Proposes Dividend for 2023	Feb. 16	CI
DKSH Holding AG Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 16	CI
DKSH : Lackluster close to 2023; FY24 outlook to improve	Feb. 16
Transcript : DKSH Holding AG, 2023 Earnings Call, Feb 16, 2024	Feb. 16
Switzerland's DKSH Posts Lower FY23 Attributable Profit, Net Sales	Feb. 16	MT
DKSH Holding AG acquired an unknown minority stake in Flummox AG.	Feb. 08	CI
DKSH to Buy Brunei-based Medical Devices Company Medipharm	Jan. 15	MT
DKSH Holding AG signed an agreement to acquire Medipharm Sdn Bhd for CHF 12 million.	Jan. 14	CI
DKSH : EPS cut (2023: -7.1%, 2024: -5.0%)	Dec. 21
Marinomed Biotech Signs Deal With DKSH to Commercialize Carragelose in Four Countries	Dec. 14	MT
DKSH Holding AG completed the acquisition of Bio-Strategy New Zealand and Bio-Strategy Australia for CHF 19 million.	Nov. 30	CI
DKSH Profit Drops in Q3	Nov. 21	MT
DKSH Holding to Acquire Australia's Bio-Strategy	Nov. 02	MT
DKSH Holding AG agreed to acquire Bio-Strategy New Zealand and Bio-Strategy Australia.	Nov. 01	CI
DKSH Converts CHF150 Million Revolving Credit into Sustainability-linked Loan	23-10-05	MT
DKSH Closes Second Sustainability-Linked Loan with Existing CHF 150 Million Revolving Credit Facility	23-10-05	CI
DKSH Buys Australian Patient Services Provider Partizan Worldwide	23-10-02	MT
DKSH Holding AG completed the acquisition of CS Company Ltd for CHF 21.5 million.	23-10-01	CI
DKSH Holding AG acquired Partizan Worldwide Pty Limited from Nigel Cowan for CHF 15.2 million.	23-10-01	CI
DKSH to Buy New Zealand-based Beauty Product Distributor CS&Co.	23-09-18	MT
DKSH Holding AG agreed to acquire CS Company Ltd.	23-09-17	CI
DKSH Unit Signs Distribution Deal With Syngenta Crop Protection	23-09-07	MT

Chart DKSH Holding AG

Duration

Period

More charts

Company Profile

DKSH Holding AG is a Switzerland-based company that provides market expansion services. The Companyâs business activities are divided into four business units: Consumer Goods, Healthcare, Performance Materials, and Technology. The Consumer Goods business unit focuses on fast moving consumer goods, food services, luxury and lifestyle products in Asia. The Healthcare business unit provides market expansion services for healthcare companies seeking to grow their business in Asia. The Performance Materials business unit offers instant access to raw materials around the world, serving the chemical, pharmaceutical, food, beverage and personal care industries. The Technology business unit offers its customers a range of technologies from European, American and Asian manufacturers with a focus on advanced machinery for industry and construction, analytical and scientific instruments, components and consumables. The Company is the parent company of DKSH Group and operates numerous subsidiaries.

Sector

Business Support Services

Calendar

2024-07-16 - Q2 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

DKSH : EPS cut (2023: -5.1%, 2024: +0.9%)

February 19, 2024 at 03:54 am EST

More Strategies

Ratings for DKSH Holding AG

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

59.6 CHF

Average target price

73.4 CHF

Spread / Average Target

+23.15%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Business Support Services

	1st Jan change	Capi.
DKSH HOLDING AG	+2.05%	4.23B
CINTAS CORPORATION	+10.55%	67.6B
JACOBS SOLUTIONS INC.	+11.64%	18.21B
RB GLOBAL, INC.	+9.40%	13.37B
INTERTEK GROUP PLC	+16.53%	9.94B
TELEPERFORMANCE SE	-32.90%	5.74B
GENPACT LIMITED	-10.98%	5.57B
MAXIMUS, INC.	-4.09%	4.91B
EXLSERVICE HOLDINGS, INC.	-4.83%	4.87B
PLUXEE N.V.	0.00%	4.3B

Other Business Support Services

DKSH Holding AG

Equities

DKSH

CH0126673539

Business Support Services

DKSH Holding AG agreed to acquire Bio-Strategy New Zealand and Bio-Strategy Australia.

EPS Revisions